Feedback / Questions
clobetasol nanosuspension (APP13007) - Formosa Labs, AimMax Therap
https://www.globenewswire.com/news-release/2024/10/16/2963893/0/en/Eyenovia-Announces-Presentation-of-Phase-3-Clobetasol-Study-Results-at-the-American-Academy-of-Ophthalmology-AAO-2024-Expo.html
Oct 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next